In the liver, we target the Alb locus in newborn, proliferating hepatocytes of a mouse model of the severe lysosomal storage disease MPS VI to achieve stable therapeutic levels of arylsulfatase B (ARSB), the lysosomal enzyme which is deficient in MPS VI. This evidence concerns the gene ARSB and lysosomal storage disease.